Headlands Technologies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,072
Closed -$284K 757
2025
Q4
$284K Buy
+15,072
New +$252K 0.02% 533
2025
Q1
Sell
-5,504
Closed -$118K 1187
2024
Q4
$118K Sell
5,504
-14,167
-72% -$345K 0.01% 635
2024
Q3
$614K Buy
+19,671
New +$489K 0.07% 300
2024
Q2
Sell
-1,770
Closed -$18.7K 1198
2024
Q1
$18.7K Sell
1,770
-2,436
-58% -$24.4K ﹤0.01% 923
2023
Q4
$50.5K Buy
+4,206
New +$34.5K 0.02% 521
2023
Q3
Sell
-5,559
Closed -$47.3K 957
2023
Q2
$47.3K Buy
+5,559
New +$46.3K 0.02% 480

Other funds holding CDNA

Headlands Technologies's CDNA Position: Q1 2026 in Review

Headlands Technologies sold out of CareDx (CDNA) in Q1 2026, closing a stake of 15,072 shares — an estimated $284K sold.

Headlands Technologies first reported a position in CDNA in Q2 2023 and held it in 6 quarters. The position peaked at $614K in Q3 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Headlands Technologies reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 15,072 CareDx shares in Q1 2026, an estimated $284K.
  • Headlands Technologies first reported a position in CareDx in Q2 2023 and held it in 6 quarters.
  • Headlands Technologies's CareDx position peaked at $614K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.